Literature DB >> 36199536

Laparoscopic vs. open lower mediastinal lymphadenectomy for Siewert type II/III adenocarcinoma of esophagogastric junction: An exploratory, observational, prospective, IDEAL stage 2b cohort study (CLASS-10 study).

Shuangxi Li1, Xiangji Ying1, Fei Shan1, Yongning Jia1, Zhemin Li1, Kan Xue1, Rulin Miao1, Yinkui Wang1, Zhaode Bu1, Xiangqian Su1, Ziyu Li1, Jiafu Ji1.   

Abstract

Objective: This study aims to verify the feasibility and efficacy of laparoscopic lower mediastinal lymphadenectomy for Siewert type II/III adenocarcinoma of esophagogastric junction (AEG). Setting: An exploratory, observational, prospective, cohort study will be carried out under the Idea, Development, Exploration, Assessment and Long-term Follow-up (IDEAL) framework (stage 2b). Participants: The study will recruit 1,036 patients with cases of locally advanced AEG (Siewert type II/III, clinical stage cT2-4aN0-3M0), and 518 will be assigned to either the laparoscopy group or the open group. Interventions: Patients will receive lower mediastinal lymphadenectomy along with either total or proximal gastrectomy. Primary and secondary outcome measures: The primary endpoint is the number of lower mediastinal lymph nodes retrieved, and the secondary endpoints are the surgical safety and prognosis, including intraoperative and postoperative lower-mediastinal-lymphadenectomy-related morbidity and mortality, rate of rehospitalization, R0 resection rate, 3-year local recurrence rate, and 3-year overall survival. Conclusions: The study will provide data for the guidance and development of surgical treatment strategies for AEG. Trial registration number: The study has been registered in ClinicalTrials.gov (No. NCT04443478). © Chinese Journal of Cancer Research. All rights reserved.

Entities:  

Keywords:  Esophagogastric junction; laparoscopy; lymph node excision; stomach neoplasms

Year:  2022        PMID: 36199536      PMCID: PMC9468012          DOI: 10.21147/j.issn.1000-9604.2022.04.08

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   4.026


  23 in total

1.  Japanese classification of gastric carcinoma: 3rd English edition.

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

2.  Laparoscopic transhiatal resection for Siewert type II adenocarcinoma of the esophagogastric junction: operative technique and initial results.

Authors:  Takahiro Kinoshita; Naoto Gotohda; Yuichiro Kato; Shinichiro Takahashi; Masaru Konishi; Shinichi Okazumi; Ryoji Katoh; Taira Kinoshita
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2012-08       Impact factor: 1.719

3.  Increased incidence of adenocarcinomas at the gastro-oesophageal junction in Dutch males since the 1990s.

Authors:  Bas P L Wijnhoven; Marieke W J Louwman; Hugo W Tilanus; Jan-Willem W Coebergh
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-02       Impact factor: 2.566

4.  Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients.

Authors:  J Rüdiger Siewert; M Feith; M Werner; H J Stein
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

5.  Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients.

Authors:  Marcus Feith; Hubert J Stein; J Rüdiger Siewert
Journal:  Surg Oncol Clin N Am       Date:  2006-10       Impact factor: 3.495

6.  Impact of lower mediastinal lymphadenectomy for the treatment of esophagogastric junction carcinoma.

Authors:  Kei Hosoda; Keishi Yamashita; Natsuya Katada; Hiromitsu Moriya; Hiroaki Mieno; Shinichi Sakuramoto; Shiro Kikuchi; Masahiko Watanabe
Journal:  Anticancer Res       Date:  2015-01       Impact factor: 2.480

Review 7.  Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease.

Authors:  Matthew F Buas; Thomas L Vaughan
Journal:  Semin Radiat Oncol       Date:  2013-01       Impact factor: 5.934

8.  Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan.

Authors:  Chika Kusano; Takuji Gotoda; Christopher J Khor; Hitoshi Katai; Hoichi Kato; Hirokazu Taniguchi; Tadakazu Shimoda
Journal:  J Gastroenterol Hepatol       Date:  2008-11       Impact factor: 4.029

9.  Clinical significance of esophageal invasion length for the prediction of mediastinal lymph node metastasis in Siewert type II adenocarcinoma: A retrospective single-institution study.

Authors:  Kazuo Koyanagi; Fumihiko Kato; Jun Kanamori; Hiroyuki Daiko; Soji Ozawa; Yuji Tachimori
Journal:  Ann Gastroenterol Surg       Date:  2018-04-10

10.  Japanese gastric cancer treatment guidelines 2018 (5th edition).

Authors: 
Journal:  Gastric Cancer       Date:  2020-02-14       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.